1. Home
  2. TRUG vs ADXN Comparison

TRUG vs ADXN Comparison

Compare TRUG & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUG
  • ADXN
  • Stock Information
  • Founded
  • TRUG 1983
  • ADXN 2002
  • Country
  • TRUG United States
  • ADXN Switzerland
  • Employees
  • TRUG N/A
  • ADXN N/A
  • Industry
  • TRUG
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUG
  • ADXN Health Care
  • Exchange
  • TRUG NYSE
  • ADXN Nasdaq
  • Market Cap
  • TRUG 8.4M
  • ADXN 8.1M
  • IPO Year
  • TRUG N/A
  • ADXN N/A
  • Fundamental
  • Price
  • TRUG $0.23
  • ADXN $10.23
  • Analyst Decision
  • TRUG Strong Buy
  • ADXN Strong Buy
  • Analyst Count
  • TRUG 1
  • ADXN 1
  • Target Price
  • TRUG $2.00
  • ADXN $30.00
  • AVG Volume (30 Days)
  • TRUG 9.9M
  • ADXN 1.4K
  • Earning Date
  • TRUG 05-15-2025
  • ADXN 06-17-2025
  • Dividend Yield
  • TRUG N/A
  • ADXN N/A
  • EPS Growth
  • TRUG N/A
  • ADXN N/A
  • EPS
  • TRUG N/A
  • ADXN 0.08
  • Revenue
  • TRUG $22,236,072.00
  • ADXN $452,495.00
  • Revenue This Year
  • TRUG $24.05
  • ADXN $86.57
  • Revenue Next Year
  • TRUG $31.65
  • ADXN N/A
  • P/E Ratio
  • TRUG N/A
  • ADXN $0.88
  • Revenue Growth
  • TRUG 8.40
  • ADXN N/A
  • 52 Week Low
  • TRUG $0.17
  • ADXN $6.51
  • 52 Week High
  • TRUG $1.52
  • ADXN $13.27
  • Technical
  • Relative Strength Index (RSI)
  • TRUG 44.78
  • ADXN 73.57
  • Support Level
  • TRUG $0.21
  • ADXN $8.08
  • Resistance Level
  • TRUG $0.25
  • ADXN $8.20
  • Average True Range (ATR)
  • TRUG 0.05
  • ADXN 0.23
  • MACD
  • TRUG 0.00
  • ADXN 0.11
  • Stochastic Oscillator
  • TRUG 21.98
  • ADXN 71.04

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: